LLY

817.59

-1.55%↓

UNH

566.44

+0.03%↑

JNJ

159.98

+0.01%↑

NVO

111.95

+0.05%↑

ABBV

203.23

-0.43%↓

LLY

817.59

-1.55%↓

UNH

566.44

+0.03%↑

JNJ

159.98

+0.01%↑

NVO

111.95

+0.05%↑

ABBV

203.23

-0.43%↓

LLY

817.59

-1.55%↓

UNH

566.44

+0.03%↑

JNJ

159.98

+0.01%↑

NVO

111.95

+0.05%↑

ABBV

203.23

-0.43%↓

LLY

817.59

-1.55%↓

UNH

566.44

+0.03%↑

JNJ

159.98

+0.01%↑

NVO

111.95

+0.05%↑

ABBV

203.23

-0.43%↓

LLY

817.59

-1.55%↓

UNH

566.44

+0.03%↑

JNJ

159.98

+0.01%↑

NVO

111.95

+0.05%↑

ABBV

203.23

-0.43%↓

Home・Aktien・VolitionRX Ltd

VolitionRX Ltd

Geschlossen

0.56 3.7

Buy Sell

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

0.55

Max

0.6

Empfehlungen
By TipRanks
Empfehlungen	Buy
12-Monats-Prognose	+809.09 upside

VolitionRX Ltd Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

31. Okt. 2024, 23:57 UTC

Heiße Aktien

Stocks to Watch: Intel, Amazon.com, Abbott Laboratories, MasTec

31. Okt. 2024, 23:43 UTC

Ergebnisse

Bud Light Owner's U.S. Sales Bounce Back After Boycott -- 4th Update

31. Okt. 2024, 23:14 UTC

Wichtige Markttreiber

Abbott Laboratories Shares Rise After Baby-Formula Verdict

31. Okt. 2024, 23:04 UTC

Top News

Australian Manufacturing Activity Edges Up From Recessionary Lows

31. Okt. 2024, 22:44 UTC

Ergebnisse

Macquarie Lifts Dividend, Extends Buyback After 1st Half Profit Rises -- Update

31. Okt. 2024, 22:14 UTC

Ergebnisse

Macquarie Lifts Dividend, Extends Buyback After 1st Half Profit Rises

31. Okt. 2024, 21:51 UTC

Top News

Australian House Prices Rise 0.3% in October

31. Okt. 2024, 21:50 UTC

Wichtige Markttreiber

Intel Shares Rally on 3Q Revenue, Upbeat Outlook

31. Okt. 2024, 23:46 UTC

Top News

Boeing Makes Another Offer to End Machinists Strike -- WSJ

31. Okt. 2024, 23:23 UTC

Top News

JPMorgan to Pay $151 Million for Alleged Misleading Disclosures, Other Charges -- Update

31. Okt. 2024, 22:51 UTC

Top News

Ergebnisse

Intel Posts More Than $16 Billion Loss but Says Sales Outlook Is Improving -- 2nd Update

31. Okt. 2024, 22:48 UTC

Top News

Ergebnisse

Amazon Shares Rise on Robust Demand, Surge in AI Infrastructure Spending -- WSJ

31. Okt. 2024, 22:40 UTC

Market Talk

Akquisitionen, Fusionen, Übernahmen

Strike Should Consider Selling Assets to Hancock -- Market Talk

31. Okt. 2024, 22:29 UTC

Ergebnisse

Macquarie Lifts Dividend, Extends Buyback After 1H Profit Rises -- Update

31. Okt. 2024, 21:59 UTC

Ergebnisse

Macquarie Lifts Dividend, Extends Buyback After 1H Profit Rises

31. Okt. 2024, 21:57 UTC

Market Talk

Ergebnisse

Intel Making Progress on $10B Cost Savings Push -- Market Talk

31. Okt. 2024, 21:55 UTC

Top News

Ergebnisse

Intel Posts More Than $16 Billion Loss but Says Sales Outlook Is Improving -- Update

31. Okt. 2024, 21:41 UTC

Top News

Ergebnisse

Chevron Could Rebound After a Middling Year -- Barrons.com

31. Okt. 2024, 21:39 UTC

Ergebnisse

Macquarie: Markets-Facing Activities A$1.4 Bln in Profit Contribution in 1H, Down 10% on Year

31. Okt. 2024, 21:39 UTC

Ergebnisse

Macquarie: Annuity-Style Activities A$1.6 Bln in Profit Contribution, Up 25% on Year

31. Okt. 2024, 21:38 UTC

Ergebnisse

Apple Beats September-Quarter Targets On iPhone, Services -- IBD

31. Okt. 2024, 21:36 UTC

Ergebnisse

Macquarie: Continues to Maintain Cautious Stance With Conservative Approach to Capital, Funding and Liquidity

31. Okt. 2024, 21:35 UTC

Ergebnisse

Macquarie: Has Acquired About A$1 Bln in Shares Through Buyback Program as of End-Oct

31. Okt. 2024, 21:35 UTC

Ergebnisse

Macquarie: Up to A$2 Bln Share Buyback Announced Last Year is Extended for 12 Months

31. Okt. 2024, 21:33 UTC

Ergebnisse

Macquarie: 1H Performance Also Driven by Further Progress in Digitalization in Banking and Financial Services

31. Okt. 2024, 21:33 UTC

Ergebnisse

Macquarie: Improved Performance in 1H Underpinned by Improved Realizations in Macquarie Asset Management

31. Okt. 2024, 21:31 UTC

Ergebnisse

Macquarie: Bank CET1 Level 2 Ratio 12.8%

31. Okt. 2024, 21:31 UTC

Ergebnisse

Macquarie: Financial Position Comfortably Exceeds Regulatory Minimum Requirements

31. Okt. 2024, 21:30 UTC

Ergebnisse

Macquarie: Assets Under Management A$917 Bln at End-Sept, Up 3% on Year

31. Okt. 2024, 21:29 UTC

Ergebnisse

Macquarie: International Income 65% of Total Income in 1H

Peer-Vergleich

Kursveränderung

VolitionRX Ltd Prognose

Kursziel

By TipRanks

809.09% Vorteil

12-Monats-Prognose

Durchschnitt 5 USD 809.09%

Hoch 5 USD

Tief 5 USD

Basierend auf 2 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für VolitionRX Ltd – Dist angeboten haben.

Rating-Konsens

By TipRanks

Buy

2 ratings

Buy

Halten

Sell

Basierend auf 2 Analysten, die in den letzten 3 Monaten Aktienbewertungen für VolitionRX Ltd – Dist abgegeben haben.

Finanzen

Andere Aktien aus dem Sektor

LLY

Eli Lilly and Co.

817.59

↓-1.55%

UNH

UnitedHealth Group Inc

566.44

↑ +0.03%

JNJ

Johnson and Johnson

159.98

↑ +0.01%

NVO

Novo Nordisk A-S

111.95

↑ +0.05%

ABBV

AbbVie Inc

203.23

↓-0.43%

VolitionRX Ltd

Übersicht

Veränderung der Aktienkurses

Empfehlungen

VolitionRX Ltd Chart

Ähnliche Nachrichten

Peer-Vergleich

VolitionRX Ltd Prognose

Kursziel

Rating-Konsens

Finanzen

Andere Aktien aus dem Sektor

Crucial information about Facebook accounts